doi: 10.1093/brain/awp296 169 PfefferG.BurkeA.Yu-Wai-ManP.CompstonD
In metabolic-related trials, Novo Nordisk leads the pack Speaking of Novo Nordisk, the company remains a leader in terms of GLP-1 clinical trials, with twice as many as the nearest competitor, Eli Lilly
The mechanisms underpinning their effects on brain functioning are not fully understood, but the general consensus attributes their benefit to antioxidant capabilities [50]
Matt Mahowald, a veteran LA nutritionist whose A-list clients include Chris Pine, Mandy Moore and Guns N Roses guitarist Slash, says some patients taking GLP-1s report being nauseated by the very prospect of food itself
Signs Your GLP-1 Dose or Timing Needs Adjustment If you notice your appetite suppression weakening or weight loss plateauing after months of consistent results, this may signal that your dose needs adjustment rather than a timing problem